Publication Name	World Journal of Clinical Cases
Manuscript ID	45306
Country	United States

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Cholestatic liver diseases: An era of emerging therapies
Manuscript Source	Invited Manuscript
All Author List	Hrishikesh Samant, David Dies, Hosein Shokouh-Amiri, Gazi Zibari, Moheb Boktor, Wuttiporn Manatsathit and Jonathan Steven Alexander
Funding Agency and Grant Number
Corresponding Author	Jonathan Steven Alexander, FACG, PhD, Professor, Department of Molecular and Cellular Physiology, Louisiana State University, School of Medicine, 1501 Kings Highway, Shreveport, LA 71103, United States. jalexa@lsuhsc.edu
Key Words	Bile acids; Drug therapy; Cholestatic liver disease; Nuclear receptor agonists
Core Tip	Anti-cholestatic therapeutic options now go beyond ursodeoxycholic acid (UDCA) and target nuclear receptors regulating bile acid (farnesoid X receptor) and G protein-coupled receptor and fibroblast growth factor-19. Additionally enterohepatic bile acid transporters and norUDCA represent potential targets in cholestatic disease.
Citation	Samant H, Manatsathit W, Dies D, Shokouh-Amiri H, Zibari G, Boktor M, Alexander JS. Cholestatic liver diseases: An era of emerging therapies. World J Clin Cases 2019; 7(13): 1571-1581

Received	2019-01-10 01:04
Peer-Review Started	2019-01-10 05:23
To Make the First Decision	2019-02-18 02:58
Return for Revision	2019-03-04 07:05
Revised	2019-06-05 14:15
Second Decision	2019-06-10 02:12
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2019-06-10 22:14
Articles in Press	2019-06-10 22:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2019-07-05 09:45

ISSN	2307-8960 (online)
Open Access	This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com